Class II HLA alleles and hepatitis B virus persistence in African Americans.

Persistence of hepatitis B virus (HBV) infection is likely due to the interplay of the virus and host immune response. Given its critical role in antigen presentation, allelic differences in the HLA complex may affect HBV persistence. In a prospectively followed African American cohort, molecular class I and class II HLA typing was done on 31 subjects with persistent HBV infection and 60 controls who cleared the infection. HBV persistence was significantly associated with two class II alleles, DQA1 *0501 (odds ratio [OR], 2.6; P=.05) and DQB1 *0301 (OR, 3.9; P=.01), the two-locus haplotype consisting of these same two alleles (OR, 3; P=. 005) and the three-locus haplotype, DQA1 *0501, DQB1 *0301, and DRB1 *1102 (OR, 10.7; P=.01). In addition, HBV persistence was associated with class II allelic homozygosity. Several class I associations with persistence were also noted but were not statistically significant after correction for multiple comparisons. These results underscore the importance of the class II-mediated immune response in recovery from HBV infection.

[1]  Ding‐Shinn Chen,et al.  Hepatitis B Virus Infection , 2007 .

[2]  K. Boucher,et al.  HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. , 1997, Transplantation.

[3]  H. Thomas,et al.  Heterozygote advantage for HLA class-II type in hepatitis B virus infection , 1997, Nature Genetics.

[4]  J J Goedert,et al.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.

[5]  G. Gerken,et al.  HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. , 1997, Journal of hepatology.

[6]  M. King,et al.  African-American HLA class II allele and haplotype diversity. , 1996, Tissue antigens.

[7]  Dominique Charron,et al.  HLA : genetic diversity of HLA functional and medical implication , 1997 .

[8]  H C Thomas,et al.  Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. , 1995, The New England journal of medicine.

[9]  J. Batchelor,et al.  HLA and hepatitis B infection , 1994, The Lancet.

[10]  J. Stephens,et al.  Polymorphic admixture typing in human ethnic populations. , 1994, American journal of human genetics.

[11]  D. Vlahov,et al.  Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. , 1994, Epidemiologic reviews.

[12]  M. Carrington,et al.  Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism. , 1992, Human immunology.

[13]  A Munoz,et al.  The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods , 1991, NIDA research monograph.

[14]  M. Nei,et al.  Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection , 1988, Nature.

[15]  C. Degott,et al.  HLA-A1, B8-phenotype association and HBs antigenemia evolution in 440 hemodialyzed patients. , 1977, Digestion.

[16]  R. Zinkernagel,et al.  Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex , 1975, Nature.